Surgery and multimodality treatment for malignant pleural mesothelioma

W. Weder, I. Opitz, R. Stahel

Source: Eur Respir Mon; 2009: 44: 407–418

Journal Issue: Thoracic Malignancies

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Weder, I. Opitz, R. Stahel. Surgery and multimodality treatment for malignant pleural mesothelioma. Eur Respir Mon; 2009: 44: 407–418

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Source: Eur Respir J 2007; 29: 117-126 Year: 2007
Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience Source: International Congress 2017 – General thoracic surgery Year: 2017
Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009
Systemic treatment of malignant mesothelioma Source: Eur Respir Mon; 2009: 44: 419–434 Year: 2009
Can we still justify pneumonectomy following induction chemotherapy? Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Role of surgery and of radiotherapy in malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection? Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005
Remediastinoscopy after neoadjuvant therapy for bronchogenic carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 180s Year: 2002
Postoperative lung cancer relapse after chemoradiation therapy Source: International Congress 2014 – Thoracic oncology grand round - an interactive session Year: 2014
Second-line chemotherapy in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002
Is prophylactic radiotherapy at intervention site always neccessary in malign pleural mesothelioma? Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Pre-operative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage nonsmall cell lung cancer Source: Breathe 2010; 7: 196-197 Year: 2010
Carcinomatous lymphangitis of a tracheal bifurcation in lung cancer: the role of neoadjuvant chemotherapy followed by surgery Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008